BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Datamonitor Report: Breast Cancer Cases on the Rise, Except in US


2/14/2011 10:33:25 AM

February 2011 -- Annual breast cancer incidence rates are expected to grow by 13% over the next decade, with only rates in the US predicted to remain constant, finds independent healthcare analyst, Datamonitor.*

More than 1 million new cases of breast cancer, the most common cancer among women, are diagnosed each year. Whilst survival rates are favourable, Datamonitor predicts that incidence cases will increase by 13% by 2019.

Sabada Dube, Senior Epidemiologist at Datamonitor, comments: “The US is the only major market where breast cancer incidence is predicted to remain constant. This is largely due to the effects of the introduction of widespread mammographic screening earlier than in other markets.

“The 2010 breast cancer screening guidelines issued by the US Preventative Task Force recommend breast cancer screening for women aged 50 years and above. Such a change in policy is likely to result in declines in future incidence rates.”

In comparison, incidence rates in the UK are expected to increase by 20% over the same period. In Japan and Spain, where the highest increases are expected, incidence rates are expected to increase by 24%.

Sabada concludes: “The major risk factors for breast cancer are environmental, hormone-related, and dietary factors. Differences between countries can largely be accounted for by the prevalence of these risk factors. For example, the trends forecast in Japan are likely a result of the Japanese continuing to adopt a more ‘westernised’ lifestyle.”

Notes for editors

* From the report Pipeline Insight: Breast and Gynecological Cancers

Sabada Dube is available for comment.

To arrange an interview or for further details regarding this release please contact Joe Dixonin the Datamonitor press office on + 44 (0)161 238 4083, or email jdixon@datamonitor.com

ABOUT DATAMONITOR

The Datamonitor Group (www.datamonitor.com) is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Sourcing, Technology and Telecoms industries. Combining our industry knowledge and experience, we assist more than 6,000 of the world’s leading companies in making better strategic and operational decisions.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES